Nurse Practitioner Sentenced for $12 Million Medicare Fraud

A Louisiana nurse practitioner has been sentenced to over seven years in prison for her role in generating fraudulent claims totaling $12 million through unnecessary cancer genetic testing billed to Medicare. Scharmaine Lawson Baker, aged 59, will also face three years of supervised release and is required to repay approximately $1.5 million. This case underscores significant issues within the Medicare system related to fraudulent billing practices and regulatory compliance requirements.

Court documents disclosed that between 2018 and 2019, Lawson Baker engaged in a scheme with a telehealth company, authorizing unwarranted cancer genetic tests after minimal patient interaction—sometimes as brief as 30 seconds. Such practices involved inappropriate screenings, including ovarian and cervical cancer tests for male patients, highlighting the ethical violations and lack of proper risk management.

Beyond failing to review or follow up on crucial test results, Lawson Baker's actions resulted in over $12 million in fraudulent Medicare claims. Laboratories involved alongside her received over $1.5 million from Medicare, while she accepted illegal bribes, unreported during her bankruptcy proceedings. In July 2025, a federal jury convicted her on six counts of healthcare fraud, showcasing the effectiveness of regulatory efforts in healthcare fraud detection.

The investigation, led by the Department of Justice, the Office of Inspector General, and the FBI, signifies joint efforts to enforce compliance and minimize fraudulent activities within federal health programs. Since 2007, initiatives by the Health Care Fraud Strike Force have led to charges against over 6,200 defendants who defrauded federal health care programs of more than $45 billion. Such measures are crucial in ensuring the integrity and sustainability of government healthcare provisions and maintaining payer-provider trust.